10 Facts About Karen Avraham

Karen B Avraham is an Israeli-American human geneticist and the first female Dean of the Tel Aviv University's Faculty of Medicine.

Karen Avraham's research focuses on the discovery and characterization of genes responsible for hereditary hearing loss.

Currently resides as the President of the Israel Society for Auditory Research, Karen Avraham held presidency with the Federation of Israel Societies for Experimental Biology as well a former board membership of the I-CORE: Gene Regulation in Complex Human Disease.

Karen Avraham is a council member of the European Molecular Biology Organization, chair of the Scientific Committee of the Fondation pour l'audition in France, council member of the Human Genome Organization, an elected member of the International Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum, and past president of the Association for Research in Otolaryngology and the Genetic Society of Israel.

Karen Avraham is an editor of Mammalian Genome, section editor of the European Journal of Human Genetics, associate editor of Human Genomics, and on the advisory editorial board of EMBO Molecular Medicine.

Karen Avraham's research has centered on the discovery of disease genes, focusing on hereditary hearing loss.

Karen Avraham leads the effort in exome sequencing for the discovery of disease genes to identify mutations that are relevant for the hearing-impaired population.

Karen Avraham's group has demonstrated that microRNAs are essential for development and function of inner ear hair cells in vertebrates and has characterized the first long non-coding RNAs and methylation in the auditory system.

Karen Avraham has published extensively in peer-reviewed journals, with an H-index of 48, and written reviews and book chapters.

Karen Avraham has been awarded the Sir Bernard Katz Prize from the Alexander-von Humboldt Foundation, the Bruno Memorial Prize from the Rothschild Foundation.